发明名称 |
CONTROLLED-RELEASE FORMULATION |
摘要 |
The present invention relates to oral controlled-release formulations of 5-(pyridinyl)-2(1H)-pyridinone compounds and their use in the treatment of a subject with heart failure, a stage, class or manifestation of heart failure, or at risk of developing or exhibiting symptoms of heart failure. The formulations of the invention release the compounds in the range of between 0.1 µg/kg body weight/minute and 20 µg/kg body weight/minute. |
申请公布号 |
CA2845228(A1) |
申请公布日期 |
2013.02.21 |
申请号 |
CA20122845228 |
申请日期 |
2012.08.16 |
申请人 |
BAKER IDI HEART & DIABETES INSTITUTE HOLDINGS LIMITED |
发明人 |
KAYE, DAVID MARTIN;KRIPPNER, GUY;MARIAPPAN, GEETHA THANGA |
分类号 |
A61K31/444;A61K9/22;A61P9/04 |
主分类号 |
A61K31/444 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|